Key drivers for each region include: North America, driven by policies supporting the use of EGCG supplements, demographics with a high demand for health supplements, and a mature ecosystem; Europe, with a strong infrastructure for research and development, investments in the healthcare sector, and a high adoption rate of EGCG supplements; Asia Pacific, with a large demographic base, increasing adoption of EGCG supplements, and growing investments in the healthcare sector; Latin America, with increasing adoption of EGCG supplements, growing investments in the healthcare sector, and a developing ecosystem; and Middle East & Africa, with a growing demographic base, increasing adoption of EGCG supplements, and rising investments in the healthcare sector.